Navigation Links
News brief: Childhood survivors of CNS cancers and leukemia have lowered educational attainment

Childhood cancer survivors who had brain or other central nervous system cancers, or leukemia, achieve lower-than-expected educational success compared with the general public, according to an article published online January 27 in the Journal of the National Cancer Institute.

This study was undertaken because previous studies on educational attainment among childhood cancer survivors were small, had contradictory findings, or were not population-based.

E.R. Lancashire, of the Centre for Childhood Cancer Survivor Studies, School of Health and Population Sciences, at the University of Birmingham in the UK, and colleagues investigated educational attainment among a cohort of over 10,000 5-year survivors of all types of childhood cancer who had completed a British Childhood Cancer Survivor Study questionnaire. Educational attainment at two levels of secondary school (advanced and ordinary levels) up to the highest level of education was considered. Results were compared with data from the general population obtained from the General Household Survey of Great Britain.

Overall, survivors of childhood cancer experience a deficit in educational attainment compared with the general public. Specifically, only those who had central nervous system neoplasms, especially if they had received radiation to the head, and leukemia survivors receiving similar treatment, performed worse than the general population. These differences were substantial and statistically significant.

"These results provide grounds for concern for survivors of CNS neoplasms and those with leukemia who were cranially irradiated, as well as reassurance regarding educational attainment among all other survivors," the authors write.


Contact: Steve Graff
Journal of the National Cancer Institute

Page: 1

Related medicine news :

1. News brief: SNPs in C-reactive protein are not associated with increased risk of cancer
2. News brief: Knockdown of E2F1 reduces invasive potential of melanoma cells
3. News brief: Dermatologic infections in cancer patients treated with EGFRI therapy
4. News brief: Long-term testicular cancer survivors at high risk for neurological side effects
5. News brief: Estrogen receptor-alpha, breast cancer patients and tamoxifen response
6. News brief: Arsenic biomethylation required for oxidative DNA damage
7. News brief: Adverse symptom reporting by patients vs. clinicians
8. News brief: Effects of aspirin and folic acid on inflammation markers for colorectal adenomas
9. JNCI news brief: STD confirmed to be associated with increased risk of prostate cancer
10. JNCI news brief: Melanosome dynamics and sensitivity of melanoma cells to chemotherapy
11. JNCI news brief: Surgeon training found effective in breast cancer sentinel lymph node trial
Post Your Comments:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: